About the journal
Blood Cancer Discovery is a journal published by American Association for Cancer Research in United States. It is listed in MEDLINE and PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- American Association for Cancer Research
- ISSN
- 2643-3230 · 2643-3249
- Country
- United States
- Access
- Not open access / not declared
- Official website
- https://bloodcancerdiscov.aacrjournals.org
Index listings
- MEDLINE · 2020-01-01
- PUBMED · 2020-09-01
- Indexing
- MEDLINE · PUBMED
- APC
- —
- Declared review time (DOAJ)
- —
- Actual review time (measured)
- 144 days received→accepted — computed from PubMed (n=100)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
699
Last recorded publication year
2026
h-index
44
i10-index
149
From OpenAlex open data (CC0).
Editorial & policy5
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSS
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 46%
- ORCID iDs in current deposits
- 49%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
Identity & continuity3
- Alternate titles
- Blood Cancer DiscovBCD
- Source type
- journal
- NLM unique ID (PubMed)
- 101764786
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Acute Myeloid Leukemia Research
- Acute Myeloid Leukemia Research
- Lymphoma Diagnosis and Treatment
- CAR-T cell therapy research
- Lymphoma Diagnosis and Treatment
- CAR-T cell therapy research
- Protein Degradation and Inhibitors
- Protein Degradation and Inhibitors
Show all subjects (50)
- Chronic Lymphocytic Leukemia Research
- Chronic Lymphocytic Leukemia Research
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Multiple Myeloma Research and Treatments
- Multiple Myeloma Research and Treatments
- Acute Lymphoblastic Leukemia research
- Acute Lymphoblastic Leukemia research
- Monoclonal and Polyclonal Antibodies Research
- Monoclonal and Polyclonal Antibodies Research
- Chronic Myeloid Leukemia Treatments
- Chronic Myeloid Leukemia Treatments
- Ubiquitin and proteasome pathways
- Ubiquitin and proteasome pathways
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Single-cell and spatial transcriptomics
- Immune Cell Function and Interaction
- Immune cells in cancer
- Single-cell and spatial transcriptomics
- Immune Cell Function and Interaction
- RNA modifications and cancer
- Immune cells in cancer
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- Epigenetics and DNA Methylation
- Cutaneous lymphoproliferative disorders research
- Histone Deacetylase Inhibitors Research
- Histone Deacetylase Inhibitors Research
- Hematopoietic Stem Cell Transplantation
- Cutaneous lymphoproliferative disorders research
- Hematopoietic Stem Cell Transplantation
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Cancer-related gene regulation
- Cancer-related gene regulation
- CNS Lymphoma Diagnosis and Treatment
- CNS Lymphoma Diagnosis and Treatment
- Virus-based gene therapy research
- RNA Research and Splicing
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ